FDA Label for Topiramate
View Indications, Usage & Precautions
Topiramate Product Label
The following document was submitted to the FDA by the labeler of this product Zydus Lifesciences Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Package Label.Principal Display Panel
NDC 70771-1656-3
Topiramate extended-release Capsules 25 mg
Rx only
30 Capsules
NDC 70771-1657-3
Topiramate extended-release Capsules 50 mg
Rx only
30 Capsules
NDC 70771-1658-3
Topiramate extended-release Capsules 100 mg
Rx only
30 Capsules
NDC 70771-1659-3
Topiramate extended-release Capsules 150 mg
Rx only
30 Capsules
NDC 70771-1660-3
Topiramate extended-release Capsules 200 mg
Rx only
30 Capsules
* Please review the disclaimer below.